Allergan Acquires Biopharm Company Repros Therapeutics
By

By
Allergan has agreed to acquire Repros Therapeutics, a development-stage biopharmaceutical company headquartered in the Woodlands, Texas, for a cash payment of $0.67 per share. Repros Therapeutics focuses on the development…

Novo Nordisk, reMYND in $412-Million Deal for Diabetes Drugs
By

By
Novo Nordisk and reMYND, a spin-off contract research organization from the University of Leuven in Belgium, have signed a license agreement to further develop reMYND’s ReS39, a therapeutic for treating…

CDMO Saneca Pharma Names Sales Director
By

By
Markus Saal has joined the senior team at Saneca Pharma, a Slovakia-based contract development and manufacturing organization (CDMO), to head up its finished dosage form sales and business development activity.…

LabVantage Releases LIMS Software to Assist in Data Integrity
By

By
LabVantage Solutions, a Somerset, New Jersey-based laboratory informatics provider, has released LabVantage 8.3, the newest version of its laboratory information management system (LIMS) software and a GxP-compliant service for data…

CMC Biologics in Supply Pact
By

By
CMC ICOS Biologics, a Bothell, Washington-based clinical and commercial manufacturer of monoclonal antibodies, coagulation factors, and other therapeutic proteins, and Harpoon Therapeutics, a biotechnology company developing T-cell recruiting biologic therapies,…

Novasep in API Supply Pact
By

By
Novasep, a Lyon, France-headquartered contract manufacturing organization and life-science service provider, has partnered with Tetraphase Pharmaceuticals, a Watertown, Massachusetts-based clinical-stage biopharmaceutical company, for the commercial manufacture of the active pharmaceutical…

BioVectra, Keryx Biopharmaceuticals to Expand Ferric Citrate Production
By

By
BioVectra, a Charlottetown, Prince Edward Island, Canada-based contract development and manufacturing organization of intermediates and active pharmaceutical ingredients (APIs), has signed a long-term supply agreement with Keryx Biopharmaceuticals, a Boston,…

Sandoz Wins Round of Litigation in Biosimilars Dispute with Amgen
By

By
Sandoz, the generics arm of Novartis, has scored a victory in ongoing litigation with Amgen over its biosimilar to Amgen’s drug Neupogen (filgrastim), a drug for treating neutropenia (low white…

Sanofi Highlights Late-Stage Pipeline, R&D Priorities
By

By
Sanofi has outlined its progress in implementing its research and development strategy, development pipeline, and milestones for 2018, as part of the company’s 2020 strategic roadmap, which includes a shift…

Quality Systems Listed Most Cited Inspection Problem in UK Regulatory Report
By

By
The UK Medicines and Healthcare products Regulatory Agency (MHRA), the UK’s national regulatory authority, has published a report, MHRA GDP Inspection Deficiency Data 2016, to identify the severity and frequency…